BCR anticorps (AA 1042-1268)
Aperçu rapide pour BCR anticorps (AA 1042-1268) (ABIN5013246)
Antigène
Voir toutes BCR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1042-1268
-
Fonction
- Polyclonal Antibody to Breakpoint Cluster Region (BCR)
-
Specificité
- The antibody is a rabbit polyclonal antibody raised against BCR. It has been selected for its ability to recognize BCR in immunohistochemical staining and western blotting.
-
Réactivité croisée
- Humain, Rat
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Immunogène
- BCR (Met1042-Thr1268)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blotting: 0.2-2 μg/mL,1:250-2500 Immunohistochemistry: 5-20 μg/mL,1:25-100 Immunocytochemistry: 5-20 μg/mL,1:25-100 Optimal working dilutions must be determined by end user.
-
Commentaires
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 500 μg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
-
- BCR (Breakpoint Cluster Region (BCR))
-
Autre désignation
- Breakpoint Cluster Region
-
Sujet
- ALL, BCR/FGFR1, BCR1, CML, FGFR1/BCR, PHL, Renal carcinoma antigen NY-REN-26
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
Antigène
-